Treatment of lung cancer
246 results
101 - 200
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients- Early versus late chest radiotherapy in patients with limited‐stage small cell lung cancer
Biomedical risk assessment as an aid for smoking cessation - Concurrent chemoradiotherapy in non‐small cell lung cancer
- Therapeutic vaccines for advanced non‐small cell lung cancer
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Prolonged cough in adults
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Post-operative radiotherapy for ductal carcinoma in situ of the breast: Cochrane systematic review
- Exercise for cancer cachexia in adults
- Psychosocial interventions for reducing fatigue during cancer treatment in adults
Daily multivitamins have minimal, if any, effect on preventing cancer in men and do not affect mortality- Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): Cochrane systematic review
- Intermittent versus continuous androgen suppression for prostatic cancer
- Biosimilar monoclonal antibodies for cancer treatment in adults
- Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults
- Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- PSA screening has marginal effect on mortality in European study (ERSPC)
- Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Vitamins E and C and selenium do not reduce risk of prostate or total cancer in men
- USPSTF review of the benefits and harms of menopausal hormone therapy
- Smoking cessation
- Physical exercise training interventions for children and young adults during and after treatment for childhood cancer
- Cannabis‐based medicines and medical cannabis for adults with cancer pain
- Myositis
- Antibody induction therapy for lung transplant recipients
- Melatonin in cancer treatment
- Second‐line chemotherapy for non‐small cell lung cancer
- Cardiovascular training versus resistance training for fatigue in people with cancer
- Guidelines for end of life care (ACP)
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
- Pharmacological treatments for fatigue associated with palliative care: Cochrane systematic review
- Oncological emergencies
- Antidepressants for depression in medical illness: Cochrane systematic review
- PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
- Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Radiotherapy for early breast cancer: Cochrane systematic review
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Platinum‐containing regimens for triple‐negative metastatic breast cancer
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy: Cochrane systematic review
- Population screening for cancer
- Organ transplant recipient in primary health care
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
- Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer
- Fewer overall hospital days with use of indwelling pleural catheters vs pleurodesis for malignant effusions
- Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
- Percutaneous ethanol injection for liver metastases
- Mindfulness‐based stress reduction for women diagnosed with breast cancer
- Impact of PSA screening on quality of life
- Anaesthetic techniques for risk of malignant tumour recurrence
- Management of adverse effects of radiotherapy
- Telephone interventions for symptom management in adults with cancer
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
- PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
- Short term benefits for laparoscopic colorectal resection
- Golimumab for rheumatoid arthritis
- Deep vein thrombosis
- Topical tretinoin may increase all-cause mortality
- Carotenoids and omega-3 fatty acids do not reduce risk of advanced AMD
- Microwave coagulation for liver metastases
- Antifibrinolytic therapy to reduce haemoptysis from any cause
- Infections in immunocompromized children
- Platinum‐containing regimens for metastatic breast cancer
- Lymphomas
- PSA for screening of prostate cancer
- Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
- Antitubercular medication in ambulatory care
- Genetic test results that identify increased risk do not change behavior
- Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
- Interventions for fatigue and weight loss in adults with advanced progressive illness
- Unintentional weight loss in adults
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
- Radiotherapy and surgery in early breast cancer